*CDRH Oncology Devices Regulatory Modernization Initiative
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The CDRH Oncology Devices Regulatory Modernization Initiative is a forecast project managed by the Food and Drug Administration. Established in August 2026, the initiative aims to improve patient access to safe and effective cancer treatment medical devices by creating consistent regulatory pathways across OPEQ offices. The primary objective is to streamline the approval process and reduce the time it takes for life-saving technologies to reach the market. The workgroup is currently prioritizing devices designed to ablate or physically destroy tumors. However, there is potential for the scope to expand to include other technologies, such as devices used in neo-adjuvant settings to decrease tumor burden and enhance the overall quality of life for patients.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Prepare for this forecast
Research this forecast and prepare for the solicitation
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
